 At four months post-hospitalization, 16.3% of patients experienced new onset dyspnea, while 4.8% experienced new onset cough. Patients with new onset dyspnea were younger, had more severe COVID-19, and more frequent pulmonary embolisms compared to those without dyspnea. Additionally, they were more likely to have fibrophic lung lesions, which were associated with lower total lung capacity and diffusing capacity of the lung for carbon monoxide. This article was authored by Etienne-Marie Jutent, Olivier Merignac, Antoine Bernier, and others.